Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monitoring of Levosimendan Administration in Patients with Pulmonary Hypertension Undergoing Cardiac Surgery and Effect of Two Different Dosing Schemes on Hemodynamic and Echocardiographic Parameters.
Ftikos P, Falara A, Rellia P, Leontiadis E, Samanidis G, Kamperi N, Piperakis A, Tamvakopoulos C, Antoniou T, Theodoraki K. Ftikos P, et al. Among authors: tamvakopoulos c. Pharmaceuticals (Basel). 2023 May 30;16(6):815. doi: 10.3390/ph16060815. Pharmaceuticals (Basel). 2023. PMID: 37375762 Free PMC article.
Combination of Doxorubicin and Antiangiogenic Agents in Drug-Eluting Beads: In Vitro Loading and Release Dynamics in View of a Novel Therapeutic Approach for Hepatocellular Carcinoma.
Krokidis M, Fakitsa D, Malagari K, Karampelas T, Fokas D, Tamvakopoulos C, Chatziioannou A. Krokidis M, et al. Among authors: tamvakopoulos c. Cardiovasc Intervent Radiol. 2024 May;47(5):661-669. doi: 10.1007/s00270-024-03714-z. Epub 2024 Apr 12. Cardiovasc Intervent Radiol. 2024. PMID: 38609583
A Novel Fluorescent Gemcitabine Prodrug That Follows a Nucleoside Transporter-Independent Internalization and Bears Enhanced Therapeutic Efficacy With Respect to Gemcitabine.
Vrettos EΙ, Kyrkou SG, Zoi V, Giannakopoulou M, Chatziathanasiadou MV, Kanaki Z, Agalou A, Bistas VP, Kougioumtzi A, Karampelas T, Diamantis DA, Murphy C, Beis D, Klinakis A, Tamvakopoulos C, Kyritsis AP, Alexiou GA, Tzakos AG. Vrettos EΙ, et al. Among authors: tamvakopoulos c. Chemistry. 2024 Sep 5;30(50):e202401327. doi: 10.1002/chem.202401327. Epub 2024 Aug 19. Chemistry. 2024. PMID: 38941241
Anti-obesity effects of Beta vulgaris and Eruca sativa-based extracts.
Markou M, Katsouda A, Papaioannou V, Argyropoulou A, Vanioti M, Tamvakopoulos C, Skaltsounis LA, Halabalaki M, Mitakou S, Papapetropoulos A. Markou M, et al. Among authors: tamvakopoulos c. Phytother Res. 2024 Sep;38(9):4757-4773. doi: 10.1002/ptr.8291. Epub 2024 Aug 9. Phytother Res. 2024. PMID: 39120436
Generation of a selective senolytic platform using a micelle-encapsulated Sudan Black B conjugated analog.
Magkouta S, Veroutis D, Papaspyropoulos A, Georgiou M, Lougiakis N, Pippa N, Havaki S, Palaiologou A, Thanos DF, Kambas K, Lagopati N, Boukos N, Pouli N, Marakos P, Kotsinas A, Thanos D, Evangelou K, Sampaziotis F, Tamvakopoulos C, Pispas S, Petty R, Kotopoulos N, Gorgoulis VG. Magkouta S, et al. Among authors: tamvakopoulos c. Nat Aging. 2024 Dec 27. doi: 10.1038/s43587-024-00747-4. Online ahead of print. Nat Aging. 2024. PMID: 39730824
Developing MYC Degraders Bearing the Von Hippel-Lindau Ligand to Target the "Undruggable" MYC.
Siokatas C, Lampropoulou A, Smina A, Soupsana K, Kontostathi M, Karra AV, Karampelas T, Politou AS, Christoforidis S, Tamvakopoulos C, Sarli V. Siokatas C, et al. Among authors: tamvakopoulos c. ACS Pharmacol Transl Sci. 2024 Nov 15;7(12):3955-3968. doi: 10.1021/acsptsci.4c00452. eCollection 2024 Dec 13. ACS Pharmacol Transl Sci. 2024. PMID: 39698270
Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury.
Moos WH, Faller DV, Glavas IP, Harpp DN, Kamperi N, Kanara I, Kodukula K, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Sampani K, Steliou K, Tamvakopoulos C, Vavvas DG, Zamboni RJ, Chen X. Moos WH, et al. Among authors: tamvakopoulos c. Biochem Pharmacol. 2022 Sep;203:115168. doi: 10.1016/j.bcp.2022.115168. Epub 2022 Jul 12. Biochem Pharmacol. 2022. PMID: 35835206 Free article. Review.
Pathogenic mitochondrial dysfunction and metabolic abnormalities.
Moos WH, Faller DV, Glavas IP, Harpp DN, Kamperi N, Kanara I, Kodukula K, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Steliou K, Tamvakopoulos C, Vavvas DG, Zamboni RJ, Sampani K. Moos WH, et al. Among authors: tamvakopoulos c. Biochem Pharmacol. 2021 Nov;193:114809. doi: 10.1016/j.bcp.2021.114809. Epub 2021 Oct 19. Biochem Pharmacol. 2021. PMID: 34673016 Free article. Review.
68 results